TP53 and cancer: Log-rank testing and multivariable Cox proportional hazards modelling were used to evaluate prognostic factors.<h4>Results</h4>Among the 1,111 cancer cases, 416 exhibited concurrent mutations in both <i>TERT</i>p and <i>TP53</i>, 387 harboured mutations exclusively in <i>TERT</i>p, 132 showed mutations only in the <i>TP53</i> gene, and 176 cases were double wild-type for both genetic regions (wt/wt).